Indeed, FPR1 activation by its natural ligands (the formylated peptide fMLF) or by commensal bacterial supernatants (Lactobacillus rhamnosus GG - LGG), but not by other lactic acid or non-probiotic bacteria (i.e., Bifidobacterium bifidum or Escherichia coli), sustains a pro-resolving response and dampens angiogenic potential in CRC cells (Liotti et al., 2022b). The gene discussed is FPR1; the disease is colorectal carcinoma.